Principia Wealth Advisory »

Takeda Pharmaceutical shares owned by Principia Wealth Advisory

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Principia Wealth Advisory from 13F filings

Historical chart of Principia Wealth Advisory investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Principia Wealth Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Principia Wealth Advisory

Quarter filed Position value Share count Share price at filing
2025-06-30 $111k 7.2k 15.46
2025-03-31 $103k 7.1k 14.34
2024-12-31 $95k 7.1k 13.24

More positions owned by Principia Wealth Advisory

Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Ftse All-world Ex-us Index Fund Etf (VEU)
Trueshares Structured Outcome Etf (SEPZ)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Eyepoint Pharmaceuticals Stock (EYPT)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Adverum Biotechnologies Stock (ADVM)
San Juan Basin Rty Tr Unit Ben Int Stock (SJT)
Ishares Gold Trust Etf (IAU)
Ishares Short Treasury Bond Etf Etf (SHV)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares Silver Trust Etf (SLV)
Schwab Fundamental Int'l Large Cap Index Etf (FNDF)

View all positions for Principia Wealth Advisory

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical